Kodak
Financials
Estimates*
USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 1.4b | 1.3b | 1.2b | 1.0b | 1.2b | 1.2b | 1.1b |
% growth | - | (5 %) | (6 %) | (17 %) | 12 % | 5 % | (7 %) |
EBITDA | 62.0m | 69.0m | 92.0m | 72.0m | 87.0m | 110m | 219m |
% EBITDA margin | 4 % | 5 % | 7 % | 7 % | 8 % | 9 % | 20 % |
Profit | 94.0m | (16.0m) | 116m | (541m) | 24.0m | 26.0m | 75.0m |
% profit margin | 7 % | (1 %) | 9 % | (53 %) | 2 % | 2 % | 7 % |
R&D budget | 64.0m | 48.0m | 42.0m | 34.0m | 33.0m | 34.0m | 34.0m |
R&D % of revenue | 5 % | 4 % | 3 % | 3 % | 3 % | 3 % | 3 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $6.0m | Early VC | |
N/A | N/A | IPO | |
* | $765m | Post IPO Debt | |
$225m | Post IPO Debt | ||
$100m | Post IPO Equity | ||
* | N/A | $285k | Grant |
Total Funding | $6.3m |
Recent News about Kodak
EditKodak, with over a century of innovation, specializes in providing advanced imaging solutions and materials science expertise to a wide range of industries. The company offers products and services such as silver films and processing chemicals for the electronics industry, direct-to-garment inks, solvent recovery systems, large format aerial films, and industrial X-ray films. Kodak also excels in specialty chemicals, antimicrobial materials, and thin film coating capabilities. The business serves clients in sectors including electronics, textiles, healthcare, and industrial manufacturing. Kodak operates on a B2B (business-to-business) model, generating revenue through the sale of its specialized products and services, as well as through licensing its technology and expertise. The company's market presence is global, catering to industries that require high-quality, innovative solutions for their imaging and material science needs.
Keywords: imaging solutions, materials science, electronics, textiles, healthcare, industrial manufacturing, specialty chemicals, antimicrobial, thin film coating, B2B.